News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Repros Therapeutics Inc. Announces Dismissal of Class Action Lawsuits
March 4, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc.® (NasdaqCM:RPRX, RPRXW and RPRXZ) today announced that the pending class action securities lawsuits that were filed against it during 2009 have been dismissed.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Vaccines
Kennedy questions vaccination guidelines following Trump’s order to break up MMR
August 24, 2026
·
2 min read
·
Tristan Manalac
Policy
Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths
August 21, 2026
·
4 min read
·
Gabrielle Masson
FDA
Trump’s FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts
August 19, 2026
·
3 min read
·
Heather McKenzie
Legal
Lilly cracks down on black market for obesity asset retatrutide with six lawsuits
August 12, 2026
·
2 min read
·
Tristan Manalac
